(Q30940050)

27 June 2017

1 reference

title

Multicentre proton magnetic resonance spectroscopy imaging of primary progressive multiple sclerosis (English)

1 reference

multicenter clinical trial

27 June 2017

main subject

0 references

primary progressive multiple sclerosis

0 references

0 references

1

Ponnada A Narayana

1 reference

27 June 2017

Jerry S Wolinsky

2

1 reference

27 June 2017

Sajja B Rao

3

1 reference

27 June 2017

Renjie He

4

1 reference

27 June 2017

Meghana Mehta

5

1 reference

27 June 2017

PROMiSe Trial MRSI Group

6

1 reference

27 June 2017

publication date

1 June 2004

1 reference

Multiple Sclerosis Journal

27 June 2017

published in

1 reference

27 June 2017

volume

10 Suppl 1

1 reference

27 June 2017

page(s)

S73-8

1 reference

Defining the clinical course of multiple sclerosis: Results of an international survey

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1035OA

Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1035OA

Primary and transitional progressive MS: a clinical and MRI cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1035OA

Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1035OA

In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1035OA

The normal appearing grey matter in primary progressive multiple sclerosis: a magnetisation transfer imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1035OA

Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1035OA

A dual approach for minimizing false lesion classifications on magnetic resonance images.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1035OA

Fast proton spectroscopic imaging employing k-space weighting achieved by variable repetition times.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1035OA

Automated proton spectroscopic image processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1035OA

Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1035OA

Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1035OA

Automatic delineation of Gd enhancements on magnetic resonance images in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1035OA

Automated single-voxel proton MRS: technical development and multisite verification

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1035OA

1H magnetic resonance spectroscopy of normal appearing white matter in primary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1035OA

A preliminary study comparing the sensitivity of serial monthly enhanced MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in primary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1035OA

Magnetic resonance spectroscopy in multiple sclerosis: window into the diseased brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1035OA

10.1191/1352458504MS1035OA

21 January 2018

Identifiers

DOI

1 reference

27 June 2017

1 reference